Magnetic resonance spectroscopy and bain diseases: Clinical applications;Spectroscopie RMN et pathologie cerebrale applications cliniques

Journal of Neuroradiology

Volumn 25, Issue 1, 1998, Pages 55-69

  Le Bas, J F ^a   Esteve F ^a   Grand, S ^a   Rubin, C ^a   Remy C ^a   Benabid, A L ^a   Decorps M ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Brain; Brain diseases; Magnetic resonance spectroscopy; Metabolism; Neuroimaging

Indexed keywords

ALANINE; AMINO ACID; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; HYPOTAURINE; INOSITOL; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID; SUCCINIC ACID; TAURINE;

ALZHEIMER DISEASE; BRAIN ABSCESS; BRAIN DISEASE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN TUMOR; DEGENERATIVE DISEASE; ENCEPHALITIS; HEPATIC ENCEPHALOPATHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; SCLEROSIS; TEMPORAL LOBE EPILEPSY; ADULT; CASE REPORT; FEMALE; MALE; METABOLISM; MIDDLE AGED;

ADULT; BRAIN DISEASES; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 0032020419     PISSN: 01509861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Achten E, Boon P, Van De Kerckhove T, Caemaert J, De Reuck J and Kunnen M. Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy. AJNR 1997 ; 18 : 1131-1139.
2. 1H-MR Spectra and spectroscopic imaging data. J Comput Assist Tomogr 1993 ; 17 (2): 191-199
3. Barker P, Gillard J, van Zijl P, Soher B, Hanley D, Agildere A, Oppenheimer S, Bryan R. Acute stroke : Evaluation with serial proton MR spectroscopic imaging Radiology 1994 ; 192 : 723-732.
4. Bernard D, Walker P, Baudouin-Poisson N, Giroud M, Fayolle H, Dumas R, Martin D, Binnert D, Brunotte F. Asymmetric metabolic profile in mesial temporal lobes : Localized H-1 MR Spectroscopy in healthy right-handed and non-right-handed subjects. Radiology 1996 ; 199 : 381-389.
5. Bizzi A, Movsas B, Tedeschi G, Phillips C, Okunieff P, Alger J, Di Chiro G. Response of non-Hodgkin lymphoma to radiation therapy : early and long-term assessment with H-1 MR Spectroscopic imaging. Radiology 1995 ; 194 : 271-276.
6. Castillo M, Kwock L and Mukherji S.K. Clinical Applications of Proton MR Spectroscopy. AJNR 1996 ; 17 : 1-15.
7. Chang L, Miller B, McBride D, Comford M, Oropilla G, Buchthal S, Chiang F, Aronow H, Ernst T. Brain lesions in patients with AIDS: H-IMR Spectroscopy. Radiologv 1995; 197 : 525-531.
8. Chong WK. Proton Spectroscopy of the brain in HIV infection : correlation with clinical, immunologie and MR imaging finding. Radiology 1993 ; 188 : 119-124.
9. Confort-Gouny S, Vion-Dury J, Nicoli F, Dano P, Donner A, Grazziani N, Gastaut JL, Grisoli F, Cozzone PJ. A multiparametric data analysis showing the potential of localized proton MR Spectroscopy of the brain in the metabolic characterization of neurological diseases. J Neurol Sciences 1993 ; 118 : 123-133.
10. Christiansen P, Toft P, Larsson HBW, Stubgaard M and Henriksen O. The concentration of N-acetyl aspartate, creatine + phosphatine, and choline in different parts of the brain in adulthood and senium. Magn Res Im 1993 ; 11 : 799-806.
11. Décorps M. Spectroscopie RMN : du spectre aux images métaboliques. In Encyclopédie Medico-chirurgicale, Paris, 1994, 35-257-A-10.
12. Ende G, Laxer K, Knowlton R, Matson G, Schuff N, Fein G, Weiner M Temporal lobe epilepsy : bilateral hippocampal metabolite changes revealed at proton MR Spectroscopy imaging. Radiology 1997 ; 202 : 809-817.
13. Furuya S, Naruse S, Ide M, Morishita H, Kizu O, Ueda S and Maeda T. Evaluation of metabolic heterogeneity in brain tumors usine 1H-chemical shift imagine method. NMR In Biomedicine 1997; 10: 25-30.
14. 1H MRS of brain abcesses versus necrotic brain tumors. Neurology 1996 ; 47 : 846-848.
15. 1H : une approche métabolique des tumeurs cérébrales et de leur suivi après irradiation externe. Rev. Med. Interne 1997 ; 18 : 865-875.
16. Grodd W, Krageloh-Mann I, Peterson D, Trefz FK, Harzer K. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet1990 ; 336 : 437-438.
17. Gruetter R, Rothman D, Novotny E, Shulman G. Localized 13C NMR Spectroscopy of myo-Inositol in the Human Brain in vivo. Magn Reson Med 1992 ; 25 : 204-210.
18. Heiss W, Heindel W, Herholz K, Rudolf J, Bunke J, Jeske J, Friedmann G. Positron emission tomography of Fluorine-18-Deoxyglucose and image-guided phosphorus 31 Magnetic Resonance Spectroscopy in brain tumors. J Nucl Med 1990 ; 31 : 302-310.
19. Kim SH, Chang KH, Song IC, Han MH, Kim HC, Kang HS, Han MC. Brain abcess and braintumor : discrimination with in vivo H-1 MR Spectroscopy. Radiology 1997 ; 204: 239-245.
20. Kimura H, Fujii Y, Itoh S, Matsuda T, Iwasaki T, Maeda M, Konishi Y, Ishii Y. Metabolic alterations in the neonate and infant brain during development : Evaluation with proton MR spectroscopy. Radiology 1995 ; 1994 : 483-489.
21. Kmoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in Vitro proton Magnetic Resonance Spectroscopy NMK Biomed 1997 ; 10: 2-12.
22. Lanfermann H, Kugel H, Heindel W, Herhols K, Heiss W, Lackner K. Metabolic changes in acute and subacute cerebral infarctions : Findings at proton MR Spectroscopic Imaging. Radiology 1995 ; 196 : 203-210.
23. Lehericy S, Dormont D, Semah F, Clemenceau S, Granat O, Marsault C, Baulac M. Developmental abnomalities of the medical temporal lobe in patients with temporal lobe epilepsy. AJNR 1995 ; 16 : 617-626.
24. Levine S, Helpern J, Welch KM, Vande Linde AM, Sawaya K, Brown E, Ramadan N, Devershwar R, Ordidge R. Human foca cerebral ischemia : evaluation of brain pH and energy metablism with P-31 NMR Spectroscopy. Radiology 1992 ; 185 : 537-544.
25. MacKay S, Ezekiel F, DiSclafani V, Meyerhoff D, Gerson J, Norman D, Fein G, Weiner M. Alzheimer disease and subcortical ischemic vascular dementia : Evaluation by combining MRImaging segmentation and H-1 MR Spectroscopy Imaging. Radiology 1996 ; 198 : 537-545.
26. Martinez-Perez I, Moreno A, Alonso J, Aguas J, Conesa G, Capdevila A, Arus C. Diagnosis of brain abcess by magnetic resonance Spectroscopy. Report of two cases. J. Neurosurg. 1997 ; 86 : 708-713.
27. Paley M. Proton Spectroscopy of the human brain. in Advanced MR Imaging Techniques, Bradley W and Bydder G, Martin Dunitz Ltd Eds, London, 1997 ; 309-332.
28. 1H Spectroscopic Imaging at 4.1.T. Magn Reson Med 1996 ; 36 : 72-77.
29. 1H NMR Spectroscopy Studies of extracts of human cerebral neoplasms. Magn Res Med 1992 ; 24: 123-136.
30. Poptani H, Gupta R, Roy R, Pandey R, Jain V, Chhabra D. Characterization of intracranial mass lesions with In vivo Proton MR Spectroscopy. AJNR 1995 ; 16 : 1593-1603.
31. Posse S, DeCarli C, Le Bihan D. Three-dimensional Echo-planar MR Spectroscopic Imasing at short echo times in the human brain. Radiology 1994 ; 192 : 733-738.
32. Preul M, Caramanos Z, Collins L, Villemure J-G, Leblanc R, Olivier A, Pokrupa R, Arnold D. Accurate, non invasive diagnosis of human brain tumors by using Proton Magnetic Resonance Spectroscopy. Nature Medicine 1996 ; 2 (3) : 321-323.
33. Prost R, Haughton V, Li S-H. Brain tumors : Localized H-1 MR Spectroscopy at 0.5. T. Radiology 1997 ; 204 : 235-238.
34. Rémy C, Fouilhé N, Barba I, Sam-Laï E, Lahrech H, Cucurella MG, Izquierdo M, Moreno A, Ziegler A, Massarelli R, Décorps M, Arus C. Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Research. 1997 ; 57 : 407-41.
35. 1H MRS of Human Brain Abcesses in vivo and in Vitro. Magn Res Med 1995 ; 34 : 508-514.
36. Roser W, Hagberg G, Mader I, Brunnschweiler H, Radue EW, Seelig J, Kappos L. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 1995 ; 33 : 811-817.
37. Ross B, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats R. Subclinical Hepatic Encephalopathy : Proton MR Spectroscopic abnormalities. Radiology 1994 ; 193 : 457-463.
38. Rutter A, Hugenholtz H, Saunders J, Smith LC. One-dimensional phosphorus-31 chemical shift imaging of human brain tumors. Invest Radiol 1995 ; 30 (6) : 359-366.
39. Shonk T, Moats R, Gifford P, Michaelis T, Mandigo J, Izumi J, Ross B. Probable Alzheimer disease : diagnosis with Proton MR Spectroscopy Radiology 1995 ; 195 : 65-72.
40. 1H MR Spectroscopy in patients with metastatic brain tumors : a multicenter study. Magn Reson Med 1995 ; 33 : 818-826.
41. Taylor J, Langston J, Reddick W, Kingsley P, Ogg R, Pui M, Kun L, Jenkins J, Chen G, Ochs J, Sanford R, Heideman R. Clinical value of proton Magnetic Resonance Spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys. 1996 ; 36 (5) : 1251-1261.
42. Tedeschi G, Bertolino A, Campbell G, Barnett A, Duyn J, Jacob K, Moonen C, Alger J, Di Chiro G. Reproductibility of Proton MR Spectroscopic Imaging Findings. AJNR 1996 ; 17: 1871-1879.
43. Tzika A, Vajapeyam S, Barnes P. Multivoxel Proton MR Spectroscopy and hemodynamic MR Imaging of childhood brain tumors : preliminary observations. AJNR 1997 ; 18: 203-218.
44. 1H-MR Spectroscopic Imaging Study. Stroke 1995 ; 26 (5) : 822-828.
45. Van Zijl PC, Chesnick AS, Des Pres D, Moonen CT, Ruiz-Cabello J, van Gelderen P. In vivo proton spectroscopy and spectroscopic imaging of [1-13]-glucose and its metabolic products. Magn Res Med 1993 ; 30 (5) : 544-551.
46. Wang Z, Zimmerman R, Sauter R. Proton MR Spectroscopy of the brain : clinically useful information obtained in assessing CNS diseases in children. AJR J 1996 ; 167 : 191-199.